top of page

After receiving a CRL for its RP1 oncolytic immunotherapy yesterday, the CEO of Replimune walks us through the program's timeline and history, and what this might mean for its future

Jul 23, 2025

1 min read

CEO Sushil Patel walks us through the decisions behind the design of the IGNYTE phase 1/2 study and the ongoing IGNYTE-3 study, he gives Replimune's impression of how the review went since the BLA was filed last November, and he discusses what the CRL could mean for the future.

https://vimeo.com/1103936856?share=copy

Recent Posts

Bay Area based Multiply Labs gave BiotechTV a behind the scenes look at the state of the art robotics that are being used today to manufacture advanced biologics and other modalities

Bay Area based Multiply Labs gave BiotechTV a behind the scenes look at the state of the art robotics that are being used today to manufacture advanced biologics and other modalities

Formation Bio announced a $600M fund it will use to acquire 10–15 drug programs over the next 3–5 years - it is a step in its plan to make drug development more efficient and become 'the next pharma'

Formation Bio announced a $600M fund it will use to acquire 10–15 drug programs over the next 3–5 years - it is a step in its plan to make drug development more efficient and become 'the next pharma'

Mizuho Senior Biotech Analyst Graig Suvannavejh gives his take on biotech's pause and discusses companies he covers with key items in the news

Mizuho Senior Biotech Analyst Graig Suvannavejh gives his take on biotech's pause and discusses companies he covers with key items in the news

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

10x_Genomics_logo.svg.png

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

Mispro is an AAALAC-accredited contract vivarium organization (CVO) offering a network of full-service vivarium rental lab facilities for preclinical in vivo rodent studies. Along with access to state-of-the-art lab spaces, Mispro supports its clients with comprehensive laboratory animal research services, including husbandry, veterinary, technical, and regulatory compliance oversight. With locations in all major U.S. biotech hubs, Mispro is committed to helping biosciences companies of all sizes and therapeutic indications achieve their research goals.

bottom of page